<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><meta name="exporter-version" content="Evernote Mac 7.14 (458244)"/><meta name="author" content="taylor.arhar@gmail.com"/><meta name="created" content="2019-03-22 17:30:34 +0000"/><meta name="source" content="desktop.mac"/><meta name="updated" content="2019-03-22 17:44:44 +0000"/><title>March 7, 2019</title></head><body><div>K18 HSQC with DJA2 Delta CT and EB3:</div><div>- GOAL: due to the low concentration of the two unlabeled proteins, HSQC was performed under the same parameters but with the labeled protein reduced to half of the previous concentration to attain 1:1 molar ratios</div><div>- see attached for calculations</div><div>- RESULTS: at the decreased K18 concentration, the majority of peaks were still present; DJA2 Delta CT did not significantly alter chemical shifts or peak intensities, suggesting that binding was not significant in this concentration regime; EB3 showed more significant decreases in peak intensities (see attached)</div><div><a href="March%207,%202019.html.resources/030719%20HSQC%20sample%20prep.xlsx">030719 HSQC sample prep.xlsx</a><br/></div><div><a href="March%207,%202019.html.resources/030719_K18_DJA2_DeltaCT_edited.pdf">030719_K18_DJA2_DeltaCT_edited.pdf</a><br/></div><div><a href="March%207,%202019.html.resources/030719_K18_EB3.pdf">030719_K18_EB3.pdf</a><br/></div><div><br/></div></body></html>
